Statistics
Publications
23
Citations
1.9K
H-Index
18
Active since
2009
Michael Dolton is an author at Roche (Switzerland) specializing in pharmacology, pharmacokinetics, and pharmacy.
Publications per year
2009–2024
23
23
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text
Michael Dolton, John E. Ray, Sharon C.-A. Chen et al. · Antimicrobial Agents and Chemotherapy · 2012 · 187 citations · Full text
1–5 of 23